Public drug program spending in Canada by top drug classes 2017
Top 10 drug classes by share of total public drug program spending in Canada in 2017*
This statistic shows the top 10 drug classes in Canada based on share of total public drug program expenditures in 2017. In that year, 2.8 percent of total drug program spending was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.
Top 10 drug classes by share of total public drug program spending in Canada in 2017*
Loading statistic...
| Share of total public drug program spending | |
|---|---|
| Tumour necrosis factor alpha inhibitors (anti-TNF drugs) | 8.2% |
| Antivirals for treatment of hepatitis C infections** | 5% |
| Antineovascularization agents*** | 4.6% |
| HMG-CoA reductase inhibitors (statins) | 2.8% |
| Other antipsychotics | 2.4% |
| Adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics | 2.3% |
| Oral protein kinase inhibitors | 2.3% |
| Selective immunosuppressants | 2.2% |
| Proton pump inhibitors (PPIs) | 2.1% |
| Direct factor Xa inhibitors | 2% |
Source
More information
Statistics on "Canadian pharmaceutical industry"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Public drug program spending in Canada by top 10 drug classes 2017
- Private sector funded drug spending Canada by top drug classes share 2013
- Private sector funded total drug spending in Canada by top drug classes 2013
- Public drug program spending in Canada by therapy share 2017
- Public drug program spending share for seniors in Canada by top drug classes 2017
- Public drug program spending for seniors in Canada by top drug classes 2017
- Public drug program spending for non-seniors in Canada by top drug classes 2017
- Share of paid beneficiaries of public drug program spending in Canada 2017
- Public drug program spending share for non-seniors in Canada by province 2017
- Public drug program spending share for seniors in Canada by province 2017
- Total public drug program spending in Canada by therapy 2017
- Public drug program spending share for generics in Canada by province 2017
- Public drug program spending share for non-seniors in Canada by top drug classes 2017
- U.S. spending on specialty medicine by type 2012-2016
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- Expenditures dedicated to drugs as share of total health spending in Canada 2005-2017
- Drug dispensing cost share by drug type in public drug plans Canada 2014/15-2015/16
- Drug spending by Rx and non-Rx in Canada by type 1975-2018
Statistics on "Canadian pharmaceutical industry"
Related topics
About Statista
